- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT02340299
Nasal HFOV Versus Nasal CPAP to Reduce Post-extubation pCO2
Nasal High Frequency Oscillation Ventilation Versus Nasal Continuous Positive Airway Pressure to Reduce Post-extubation pCO2 in Very Low Birth Weight Infants: a Randomized Controlled Trial
Panoramica dello studio
Stato
Intervento / Trattamento
Descrizione dettagliata
Randomized controlled clinical trial comparing nHFOV vs nCPAP immediately after extubation of VLBW infants.
Intervention and treatment protocol as described for the two study arms.
Definition of treatment failure (infant meets at least one criterion):
- Sustained pCO2 >80 mmHg and pH <7.20 confirmed by arterial or capillary blood gas analysis in spite of optimized non-invasive respiratory support with maximum settings as defined above.
- Fraction of inspired oxygen (FiO2) >0.6 to maintain peripheral oxygen saturation as measured by pulse oximetry (SpO2) at 90-94% in spite of optimized non-invasive respiratory support with maximum settings as defined above.
- Reintubation (study patients may be intubated at any time, due to clinical considerations, with or without reaching another criterion of "treatment failure").
Sample size:
Assuming a variability of the paCO2 as previously reported for difficult-to-wean preterm infants in our unit (Czernik C, J Matern Fetal Neonatal Med 2012) and a treatment failure rate of 22% within 72 hours after extubation, we calculated a sample size of 34 patients in each study arm to detect a difference in the paCO2 of 7 mmHg, using a two-sided significance of 0.05 and a power of 0.8.
Randomization:
Sequence generation by an independent statistician and a study nurse. Block randomization using at least two different block sizes. Allocation concealment using sequentially numbered opaque sealed envelopes.
Data monitoring:
By an independent statistician.
Tipo di studio
Iscrizione (Effettivo)
Fase
- Non applicabile
Contatti e Sedi
Luoghi di studio
-
-
-
Berlin, Germania
- Dpt. of Neonatology, Charité - Universitätsmedizin Berlin
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Descrizione
Inclusion Criteria:
- Gestational age <32+0 weeks
- Birth weight <1500 g
- Received mechanical ventilation via an endotracheal tube for ≥120 h
- Caffeine treatment according to unit guidelines
- paCO2 <65 mmHg with pH >7.2
- FiO2 25-40% to maintain SpO2 at 90-94%.
- Time-cycled, pressure-controlled ventilation: PIP ≤22 cm H2O, PEEP ≤6 cm H2O; Volume guarantee ventilation: Working Ppeak ≤22 cm H2O, PEEP ≤6 cm H2O; High frequency oscillation ventilation: Pmean ≤12 cm H2O, Amplitude ≤30 cm H2O
- Decision of the attending clinician to extubate
Exclusion Criteria:
- Major congenital malformation requiring surgery
- Duct-dependent congenital heart disease
- Neuromuscular disease
- Participation in another randomized controlled trial
- Death before reaching the eligibility criteria
- Hydrocortisone treatment at the time of enrolment
- Chronological age >28 days
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Trattamento
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione parallela
- Mascheramento: Nessuno (etichetta aperta)
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
---|---|
Sperimentale: nHFOV
Immediately after extubation, nHFOV is provided via binasal prongs. Ventilator settings: Frequency set at 10 Hz, I:E ratio 33:66, amplitude 20 cm H2O, Pmean 8 cm H2O, flow 7 l/min. Set FiO2 to maintain SpO2 at 90-94%. The weaning process is left to the discretion of the attending physician. Maximum amplitude 30 cm H2O, minimum frequency 9 Hz, maximum Pmean 8 cm H2O. For infants in the nHFOV-group who "fail" nHFOV (see definition below), but do not need immediate reintubation, a non-invasive "Rescue-Treatment" may be provided. The decision to attempt "Rescue-Treatment", the mode of respiratory support and the ventilator settings used are at the discretion of the attending clinician. |
Extubation to ventilator-derived nHFOV using binasal prongs
|
Comparatore attivo: nCPAP
Immediately after extubation, nCPAP is provided via binasal prongs. Ventilator settings: CPAP level set at 8 cm H2O, flow 7 l/min. Set FiO2 to maintain SpO2 at 90-94%. The weaning process is left to the discretion of the attending physician. Maximum CPAP level 8 cm H2O, maximum flow 8 l/min. For infants in the nCPAP-group who "fail" nCPAP (see definition below), but do not need immediate reintubation, "Rescue-nHFOV" via binasal prongs may be provided. The decision to attempt "Rescue-nHFOV" and the ventilator settings used are at the discretion of the attending clinician. |
Extubation to ventilator-derived nCPAP using binasal prongs
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
---|---|---|
paCO2 at 72 h After Extubation
Lasso di tempo: 64 h to 80 h
|
Partial pressure of arterial carbon dioxide assessed between 64 and 80 hours, and on average 72 hours.
|
64 h to 80 h
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
---|---|---|
pH at 2 h After Extubation
Lasso di tempo: within the first 6 h after extubation
|
within the first 6 h after extubation
|
|
paO2 at 2 h After Extubation
Lasso di tempo: within the first 6 h after extubation
|
within the first 6 h after extubation
|
|
paCO2 at 2 h After Extubation
Lasso di tempo: within the first 6 h after extubation
|
within the first 6 h after extubation
|
|
Base Excess at 2 h After Extubation
Lasso di tempo: within the first 6 h after extubation
|
within the first 6 h after extubation
|
|
pH at 72 h After Extubation
Lasso di tempo: 64-80 h after extubation
|
64-80 h after extubation
|
|
paO2 at 72 h After Extubation
Lasso di tempo: 64-80 h after extubation
|
64-80 h after extubation
|
|
Base Excess at 72 h After Extubation
Lasso di tempo: 64-80 h after extubation
|
64-80 h after extubation
|
|
Successful Extubation
Lasso di tempo: 72 h after extubation
|
Defined as the number of patients breathing spontaneously in their assigned treatment group for ≥72h without reaching the criterion of "treatment failure"
|
72 h after extubation
|
Treatment Failure
Lasso di tempo: within 7 days after extubation
|
Defined as the number of patients reaching the criterion of "treatment failure"
|
within 7 days after extubation
|
Reintubation
Lasso di tempo: within 7 days after extubation
|
Defined as the number of patients being reintubated
|
within 7 days after extubation
|
Highly Viscous Secretions
Lasso di tempo: within 72 hours after extubation
|
Defined as the documented number of episodes of airway obstruction due to highly viscous secretions per patient
|
within 72 hours after extubation
|
Other Adverse Effects
Lasso di tempo: until discharge
|
Incidences of the following adverse effects: Intraventricular hemorrhage III°-IV° (Papile), surgical necrotizing enterocolitis, pneumothorax, pulmonary interstitial emphysema, persistent ductus arteriosus requiring surgical closure, retinopathy of prematurity requiring laser treatment and/or injection of bevacizumab, death or moderate to severe bronchopulmonary dysplasia (Jobe) at 36 weeks' gestational age, periventricular leukomalacia
|
until discharge
|
Duration of Respiratory Support
Lasso di tempo: until discharge
|
Total duration of mechanical ventilation, total duration of supplemental oxygen, number of infants discharged with home oxygen
|
until discharge
|
Altre misure di risultato
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
---|---|---|
pH at 2 h After Switch to "Rescue Treatment"
Lasso di tempo: within the first 6 h after switch to "rescue treatment"
|
within the first 6 h after switch to "rescue treatment"
|
|
paO2 at 2 h After Switch to "Rescue Treatment"
Lasso di tempo: within the first 6 h after switch to "rescue treatment"
|
within the first 6 h after switch to "rescue treatment"
|
|
paCO2 at 2 h After Switch to "Rescue Treatment"
Lasso di tempo: within the first 6 h after switch to "rescue treatment"
|
within the first 6 h after switch to "rescue treatment"
|
|
Base Excess at 2 h After Switch to "Rescue Treatment"
Lasso di tempo: within the first 6 h after switch to "rescue treatment"
|
within the first 6 h after switch to "rescue treatment"
|
|
Successful Rescue
Lasso di tempo: 72 h after switch to "rescue" treatment
|
Defined as spontaneous breathing for ≥72h after starting "rescue" therapy, without reaching the criterion of "treatment failure"
|
72 h after switch to "rescue" treatment
|
Collaboratori e investigatori
Investigatori
- Investigatore principale: Christoph Czernik, MD PhD, Charite University, Berlin, Germany
Pubblicazioni e link utili
Studiare le date dei record
Studia le date principali
Inizio studio (Effettivo)
Completamento primario (Effettivo)
Completamento dello studio (Effettivo)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Stima)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
- EA2/011/12
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .
Prove cliniche su nHFOV
-
Alexandria UniversityCompletatoInstabilità emodinamica | Ecocardiografia | Ventilatore polmonare; NeonatoEgitto
-
Daping Hospital and the Research Institute of Surgery...CompletatoSindrome da stress respiratorio | Neonato pretermineCina
-
Jiulongpo No.1 People's HospitalSconosciutoNeonato pretermineCina
-
University of ManitobaSospesoSindrome da stress respiratorioCanada
-
Fondazione Poliambulanza Istituto OspedalieroFondazione Policlinico Universitario Agostino Gemelli IRCCS; Fondazione IRCCS... e altri collaboratoriCompletatoNascita prematura | Sindrome da stress respiratorioItalia, Lituania
-
The Hospital for Sick ChildrenCompletatoTachipnea transitoria del neonatoTacchino
-
Xingwang ZhuUniversity of Southern California; Children's Hospital of Fudan University; The... e altri collaboratoriCompletato
-
Daping Hospital and the Research Institute of Surgery...ReclutamentoVentilazione ad oscillazione nasale ad alta frequenzaCina
-
Daping Hospital and the Research Institute of Surgery...The First Affiliated Hospital of Anhui Medical University; LanZhou University; Beijing... e altri collaboratoriCompletatoI neonati intubati erano destinati all'estubazione utilizzando strategie di ventilazione non invasiveCina
-
Gao WeiWeiSconosciuto